Actual Medicinal Product (AMP) Dacadis MR 30mg tablets (Viatris UK Healthcare Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
This medicinal product does not require any special storage conditions.
- Provenance
-
This compatibility recommendation is derived from Diamicron 30mg MR tablets (Servier Laboratories Ltd).
- Generic
- Gliclazide
- Formulation
- Gliclazide 30mg modified-release tablets
-
Gliclazide
-
Gliclazide 30mg modified-release tablets
-
Dacadis MR 30mg tablets (Viatris UK Healthcare Ltd)
-
-
Gliclazide 80mg tablets